Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Non Operating Income (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Non Operating Income for 3 consecutive years, with -$2000.0 as the latest value for Q4 2025.

  • For Q4 2025, Non Operating Income fell 100.48% year-over-year to -$2000.0; the TTM value through Dec 2025 reached $3.4 million, up 2045.28%, while the annual FY2025 figure was -$14000.0, 108.92% down from the prior year.
  • Non Operating Income hit -$2000.0 in Q4 2025 for Artiva Biotherapeutics, up from -$3000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $1.9 million in Q1 2025 and bottomed at -$1.7 million in Q2 2024.
  • Average Non Operating Income over 3 years is $382181.8, with a median of $420000.0 recorded in 2024.
  • On a YoY basis, Non Operating Income climbed as much as 1626.0% in 2024 and fell as far as 406.11% in 2024.
  • Artiva Biotherapeutics' Non Operating Income stood at $44000.0 in 2023, then surged by 854.55% to $420000.0 in 2024, then tumbled by 100.48% to -$2000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$2000.0, -$3000.0, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.